In summary, L-carnitine is an essential compound synthesized by the body and obtained through diet, vital for transporting fats into mitochondria to produce energy
With the popularity of GLP-1 agonists ever-increasing and over 150 GLP-1 drug candidates in development [3], the field is continually expanding, most recently into oncology and obesity-related cancers.[4] While most approved GLP-1RAs require subcutaneous injection, substantial work is being undertaken to move toward oral GLP-1 therapies [5], such as Rybelsus which was the first oral GLP-1RA approved by the FDA in 2019
Rotate to a completely different muscle group for the next injection and verify needle length
But muscle tissue also gets broken down for amino acids and glucose
Therefore, following the approval of Exenatide, development of GLP-1 drugs mainly focused on two directions: developing long-acting GLP-1RAs and oral GLP-1RAs (Figure 3)
Algorithm for management of Type 2 diabetes